BioPharma Observer | Stewart Lyman | Substack

All of my articles, no matter where they were published

Jul 12, 2022

Drug discovery and development is a difficult process that takes considerable expertise in both the research and business realms. Seattle (and the rest…

Mar 22

This page details the fates of a number of Seattle or NW based biotech companies that are no longer with us because they were acquired, merged, or…

Mar 21

More great reads you're sure to enjoy

Jul 12, 2022

Originally published 6/15/2021

Jul 11, 2022

Originally published 6/5/2020

Jul 11, 2022

Originally published 3/19/2020

Jul 11, 2022

Originally posted 8/18/2018

Jul 11, 2022

Recommendations

Eric Topol

Your Local Epidemiologist

Katelyn Jetelina

Counterpoint

Letters from an American

Heather Cox Richardson

A.R. Moxon

BioPharma Observer

About Archive Recommendations Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts